EUCTR2016-000896-26-DK进行中(未招募)1 期
Effect of Tadalafil on cerebral large arteries in stroke patients. - Tadalafil and apoplexia.
Herlev Gentofte Hospital0 个研究点开始时间: 2016年3月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Radiological evidence of cerebral small vessel disease defined as: MRI evidence of lacunar infarct(s) (= 1.5 cm maximum diameter) and/or confluent deep white matter leukoaraiosis (= grade 2 on Fazekas scale).
- •2.Clinical evidence of cerebral small vessel disease defined as:
- •a) lacunar stroke syndrome with symptoms lasting >24 hours, occurring at least 5 months previously;
- •b) transient ischaemic attack lasting < 24 hours with limb weakness, hemi-sensory loss or dysarthria at least 5 months previously AND with MR DWI performed acutely showing lacunar infarction, OR if MRI is not performed within 10 days of TIA, a lacunar infarction in an anatomically appropriate position is demonstrated on a subsequent MRI;
- •3.Age = 50 years.
- •4.Imaging of the carotid arteries with Doppler ultrasound, CT angiography or MR angiography in the previous 12 months, demonstrating < 70% stenosis in both internal carotid arteries.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •1.Known diagnosis of dementia
- •2. Pregnancy or nursing women
- •3.Cortical infarction (>1.5 cm maximum diameter)
- •4.Systolic BP < 90 and/or diastolic BP < 50
- •5.eGFR < 30 ml/min/1,73 m2
- •6.Severe hepatic impairment
- •7.History of Lactose intolerance
- •8.Concomitant use of PDE5 inhibitors e.g. sildenafil, tadalafil, vardenafil
- •9.Patients receiving nicorandil and nitrates e.g. isosorbide mononitrate, isosorbide dinitrate, glyceryl trinitrate
- •10.Body weight > 130kg
- •11.Uncontrolled cardiac failure
- •12.Persistent or paroxysmal atrial fibrillation
- •13.History of ‘sick sinus syndrome’ or other supraventricular cardiac conduction conditions such as sinoatrial or atrioventricular block
- •14.Uncontrolled COPD
- •15.Stroke or TIA within the last 5 months.
- •16.MRI not tolerated or contra-indicated : MRI exclusion criteria -Participant has a cardiac pacemaker; recent surgery; vascular clips; metal implants or joint replacements that are not compatible with MRI; have had metal fragments in their eyes; has ever worked on a lathe; has shrapnel from a war injury; possibility of pregnancy
- •17.Known monogenic causes of stroke i.e. CADASIL
- •18. The patient does not wish to know important results from MRI
- •19.Unable to provide informed consent
- •20. Not possible to localise a. cerebri media bilaterally on inclusion day with Transcranial Doppler.
研究者
相似试验
已完成
2 期
Effect of Tadalafil on Cerebral Large Arteries in StrokeStroke, LacunarCerebral Small Vessel DiseasesNCT02801032Christina Kruuse20
已完成
不适用
Tadalafil: effects on blood pressure and arterial stiffness in systolic hypertensioHypertensionISRCTN06158636Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)15
已完成
2 期
Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) TrialDementia, VascularNCT02450253St George's, University of London55
已完成
不适用
Effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms secondary to benign prostate hyperplasiabenign prostate hyperplasiaJPRN-UMIN000016034Department of Urology, Kyorin University School of Medicine50
已完成
不适用
Study on the effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms due to benign prostatic hyperplasiaPatients with lower urinary tract symptoms due to benign prostatic hyperplasiaJPRN-UMIN000020658Hidehiro Kakizaki22
